Anitttttta
The biggest issue with RWA is not asset tokenization or bringing assets on-chain; high-quality assets are not rare, what’s scarce is liquidity.
Currently, the most successful on-chain RWA are all US Treasuries, money market funds, and short-term credit.
Why? Not because they need to be tokenized the most, but because they are the easiest to sell and settle.
This is called efficiency capture, not market transformation.
Assets that truly need RWA are a building with only 10% equity sold, a research patent not yet in clinical trials, a non-standardized, illiquid private credit with no secondary m
View OriginalCurrently, the most successful on-chain RWA are all US Treasuries, money market funds, and short-term credit.
Why? Not because they need to be tokenized the most, but because they are the easiest to sell and settle.
This is called efficiency capture, not market transformation.
Assets that truly need RWA are a building with only 10% equity sold, a research patent not yet in clinical trials, a non-standardized, illiquid private credit with no secondary m











